Open access · US-GOV
via ClinicalTrials.gov Clinical trial
Human Mesenchymal Stem Cell (hMSC) Infusion for Anti-Aging and REGENerative Therapy
Authors not listed
Landmark Medical Centre Sdn Bhd · 2020
Abstract
To evaluate the safety and efficacy of human Mesenchymal Stem Cell (hMSC) infusion therapy, in preserving general wellness and ameliorating or reversing the effects of aging in our study population
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- ClinicalTrials.gov
- Canonical
- link ↗
- Fetched
- 2026-10-23 MST
Cite this
APA
Anonymous. (2020). Human Mesenchymal Stem Cell (hMSC) Infusion for Anti-Aging and REGENerative Therapy. <em>Landmark Medical Centre Sdn Bhd</em>. https://clinicaltrials.gov/study/NCT04174898
Vancouver
Anonymous. Human Mesenchymal Stem Cell (hMSC) Infusion for Anti-Aging and REGENerative Therapy. Landmark Medical Centre Sdn Bhd. 2020.
BibTeX
@misc{anon2020HumanM,
title = {Human Mesenchymal Stem Cell (hMSC) Infusion for Anti-Aging and REGENerative Therapy},
author = {Anonymous},
journal = {Landmark Medical Centre Sdn Bhd},
year = {2020},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Experimental Gerontology 2005
Citation only
Mesenchymal stem cell aging
Journal of Clinical Orthopaedics and Trauma 2016
Open access · OA
Mesenchymal stem cell therapy for osteoarthritis
Journal of the American College of Cardiology 2015
Open access · OA
Effect of Aging on Human Mesenchymal Stem Cell Therapy in Ischemic Cardiomyopathy Patients
Stem cells in clinical applications 2016
Citation only
Mesenchymal Stem Cell Therapy in Rheumatoid Arthritis
Elsevier eBooks 2018
Citation only
Aging of Human Mesenchymal Stem Cells
Journal of Cerebral Blood Flow & Metabolism 2017
Open access · OA